We previously discovered potential urine protein biomarkers indicating the occurrence of bladder cancer, including afamin, adiponectin, complement C4 gamma chain, apolipoprotein A-II precursor, ceruloplasmin, and prothrombin using multiplex reaction monitoring mass spectrometry (MRM-MS) [67]. This evidence concerns the gene ADIPOQ and urinary bladder carcinoma.